Safety of neuraminidase inhibitors against novel influenza A (H1N1) in pregnant and breastfeeding women

Toshihiro Tanaka; Ken Nakajima; Atsuko Murashima; Facundo García‐Bournissen; Gideon Koren

doi:10.1503/cmaj.090866

Home SearchPaper Details

Safety of neuraminidase inhibitors against novel influenza A (H1N1) in pregnant and breastfeeding women

Toshihiro Tanaka, Ken Nakajima, Atsuko Murashima, Facundo García‐Bournissen, Gideon Koren, Shinya Ito

Canadian Medical Association (2009) • Volume 181, Issue 1-2, Pages 55-58

PDF Available

Abstract

A new strain of influenza A virus (novel influenza A H1N1) that originated in swine has rapidly spread from the initial outbreak in Mexico and the southern United States to Canada and many countries in Europe and Asia. Consequently, the World Health Organization raised the level of alert for an

Quick Actions

Read Full Paper

Publication Info

DOI

10.1503/cmaj.090866

Language

English

Topic

Influenza Virus Research Studies

Keywords

Breastfeeding, Neuraminidase, Outbreak, Virology, Medicine, Pregnancy, Virus, Pandemic, Environmental health, Human mortality from H5N1, Neuraminidase inhibitor, Influenza A virus, Coronavirus disease 2019 (COVID-19), Pediatrics, Biology, Internal medicine, Disease, Infectious disease (medical specialty)

Published

June 15, 2009

Citations

168 citations

FWCI

20.33

External Resources

DOI Link OpenAlex

Safety of neuraminidase inhibitors against novel influenza A (H1N1) in pregnant and breastfeeding women

Abstract

Quick Actions

Publication Info

External Resources

Suggested Papers

PI3K/AKT/mTOR signaling transduction pathway and targeted therapies in cancer

Third-generation versus first-generation EGFR tyrosine kinase inhibitors in Asian patients with advanced EGFR mutant non-small cell lung cancer: a meta-analysis of randomized controlled trials

Resetting response patterns during sustained ventricular tachycardia: relationship to the excitable gap.

Suggested Papers

Suggested Papers

PI3K/AKT/mTOR signaling transduction pathway and targeted therapies in cancer

Third-generation versus first-generation EGFR tyrosine kinase inhibitors in Asian patients with advanced EGFR mutant non-small cell lung cancer: a meta-analysis of randomized controlled trials

Resetting response patterns during sustained ventricular tachycardia: relationship to the excitable gap.